Novartis to spin off, list Sandoz business

The Swiss pharmaceutical company said Sandoz would be based in Switzerland and listed locally alongside a an American depositary receipt program in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.